<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In order to examine the effect of insulin-like growth factor-1 (IGF-1) on ischemic brain injury, IGF-1 was applied topically on the surface of reperfused rat brain after 60 min of transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="1" pm="."><plain>In contrast to the cases treated with vehicle, the <z:mpath ids='MPATH_124'>infarct</z:mpath> area was greatly reduced at 24 h of reperfusion by treatment with IGF-1 </plain></SENT>
<SENT sid="2" pm="."><plain>Terminal deoxynucleotidyl transferase mediated <z:chebi fb="0" ids="17625">dUTP</z:chebi>-<z:chebi fb="1" ids="15956">biotin</z:chebi> in situ nick labeling (TUNEL) staining and immunoreactivity for <z:chebi fb="15" ids="28087">glycogen</z:chebi> synthase kinase 3beta (GSK3beta) were also markedly reduced in the brains with IGF-1 treatment </plain></SENT>
<SENT sid="3" pm="."><plain>The present results suggest that the treatment with IGF-1 significantly ameliorates brain injury after transient focal <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e> associated with the reduction of TUNEL and GSK3beta stainings </plain></SENT>
</text></document>